This week, Microsoft (NASDAQ:MSFT) announced a partnership with KIND Financial, a California-based startup with ‘seed-to-sale’ tracking technology.
The news comes just a few days after Microsoft announced it would acquire LinkedIn (NYSE:LNKD) for $26 billion.
KIND bills itself as “the leader in technology for cannabis compliance,” and was chose to participate in Microsoft’s newly created Health and Human Services Pod for Managed Service Providers. The goal is to acquire contracts with governments and regulatory agencies to help regulate and monitor all aspects of cannabis compliance.

The move is significant. As Nathaniel Popper of the New York Times points out, it makes Microsoft one of the first big companies to ‘break the corporate taboo on pot.’ While Microsoft is sticking with government compliance—staying away from banking and other services offered by KIND—it’s still dipping its toes into the water.
“Nobody has really come out of the closet, if you will,” Matthew A. Karnes, founder of Green Wave Advisors, told Popper. “It’s very telling that a company of this caliber is taking the risk of coming out and engaging with a company that is focused on the cannabis business.”
Certainly, compliance has been one of the biggest issues facing cannabis stocks. Chris Milenkevich started Gotham Cannabis Associates, a firm that specializes in due diligence on publicly traded cannabis companies, explained in a recent interview that many banks won’t work with marijuana companies in the US since pot still isn’t legal at the federal level. Even at the state level, recreational marijuana may be legal, but it is still heavily restricted, meaning that it’s easy for unwelcoming communities to find a reason to shut operations down.
What’s more, cannabis social media platform was MassRoots recently rejected for a Nasdaq listing, stating that it could aid in the use and dealing of an illegal substance. As per Reuters, MassRoots CEO Isaac Dietrich sees that decision setting up a precedent for others in the cannabis space.
Still, for KIND Financial Founder and CEO David Dinenberg, ensuring compliance with government regulations is key for moving forward.
“No one can predict the future of cannabis legalization, however, it is clear that legalized cannabis will always be subject to strict oversight and regulations similar to alcohol and tobacco; and, KIND is proud to offer governments and regulatory agencies the tools and technology to monitor cannabis compliance,” he said in a statement“I am delighted that Microsoft supports KIND’s mission to build the backbone for cannabis compliance.”
Don’t forget to follow us @INN_Resource for real-time news updates!

Securities Disclosure: I, Teresa Matich, hold no direct investment interest in any company mentioned in this article.

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less